Programs

As a private-sector research enterprise, Canadian Health Policy Institute (CHPI) hosts topically focused research programs, chaired by CHPI affiliated scholars and sponsored by non-government sources. Active programs are shown below.

Access to Innovative Medicines

RESEARCH CHAIR: Brett J Skinner, Ph.D.

This research program is focused on evidence-based analysis of policy issues related to access to innovative medicines for Canadians. The program is partially funded by sponsors including:

CHP blogazine

Gaps in coverage for take-home cancer drugs in Canada

By Roxana Sultan, Vice Chair and Member, Board of Directors, Canadian Cancer Society Ontario Divis »

Opinions

Pharmacare is unnecessary, bad for privately insured Canadians and costly for taxpayers.

Brett Skinner | Financial Post | 10/18/2019 »
Civil servants get the Rolls Royce of pharmacare while party leaders can't even muster a decent plan

Nigel Rawson and John Adams | National Post | 10/14/2019 »
New rules will keep the best medications from desperate Canadians

Nigel S. B. Rawson and John Adams | Financial Post | September 12, 2019 »

News

Health Canada requires hospitals to report adverse drug reactions and medical device incidents.

Health Canada recently announced new regulations t »
CADTH and BC Pharmacare move to ease entry of biosimilar drugs.

The Canadian Agency for Drugs and Technologies in »
Council on the Implementation of National Pharmacare releases final report.

The federal Council on the Implementation of Natio »

Programs

Access to Innovative Medicines

RESEARCH CHAIR: Brett J Skinner, Ph.D.

Log in

Log in

Register